Companies: 10,795·Total market cap: $144.5T
Myovant Sciences Ltd.

Myovant Sciences Ltd.

MYOVNYSEHealthcare
$26.98
$-0.01(-0.04%)
Market Cap$2.6B
P/E Ratio—
52W High$27.06
52W Low$7.67
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Myovant Sciences Ltd. (MYOV) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MYOV · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.91myov eps ttm · myov earnings per shareEarnings history
PE Ratio (TTM)—myov pe ratio ttm · myov price to earningsPE Ratio deep dive
Revenue (TTM)$379.1Mmyov revenue ttm · myov annual revenueFull revenue history
Dividend YieldNo Dividenddoes myov pay dividends · myov dividend yieldDividend history
Shares Outstanding93.0Mmyov shares outstanding · myov floatShares outstanding history
Next EarningsTBAmyov earnings date · myov next earningsEarnings history

Explore Myovant Sciences Ltd. Data

myov stock data · financials
Market Cap$2.6Bmyov market cap · myov valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes myovant sciences ltd. pay dividends · myov dividend yield
Revenue$231.0M+289.39%myovant sciences ltd. annual revenue · myov revenue
EarningsEPS $-2.22+21.55%myov earnings · myov eps
PE Ratio—myov pe ratio · myov price to earnings

Financial Snapshot

Full Financials
FY 2022Revenue$231.0M▲ +289.39% YoY
202020212022
myovant sciences ltd. revenue · myov revenue 2022
FY 2022Net Income-$206.0M▲ +19.27% YoY
202020212022
myovant sciences ltd. net income · myov profit 2022
FY 2022EPS$-2.22▲ +21.55% YoY
202020212022
myov eps · myovant sciences ltd. earnings per share 2022
TTM:Revenue: $379.1MNet Income: -$183.8MEPS: $-1.91View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis myov a buy · myov analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$26.98Current
$—Avg Target
$—High
myov price target · myov 12 month forecast

Total: 1 · Buy rate: 100.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M-0.04%
3M+0.30%
YTD+0.19%
1Y+86.07%
5Y+27.93%

About Myovant Sciences Ltd.

CEODavid C. Marek
IPO DateOct 27, 2016
Employees579
CountryGB
Websitemyovant.com

Myovant Sciences Ltd. is a biopharmaceutical company focused on innovating healthcare solutions for both women and men. Its flagship product is relugolix, an orally administered, once-daily small mole…

BiotechnologyHealthcareNYSEGB

what is myovant sciences ltd. · myov stock overview · myovant sciences ltd. company profile · who is myovant sciences ltd. ceo · myov NYSE · myovant sciences ltd. headquarters · myovant sciences ltd. business segments

About Stock Overview & Key Data

Myovant Sciences Ltd. (MYOV) is a Healthcare company in the Biotechnology industry, listed on NYSE since Oct 27, 2016. As of the latest trading session, MYOV stock price is $26.98, with a market capitalization of $2.6B. The stock has returned +86.07% over the past 12 months and +0.19% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Myovant Sciences Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Myovant Sciences Ltd. reported revenue of $231.0M and net income of -$206.0M. For detailed data — including Myovant Sciences Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Myovant Sciences Ltd. (MYOV) stock price is $26.98. The stock is traded on NYSE under the ticker symbol MYOV. The 52-week range is $7.67 – $27.06.

MYOV stock priceMYOV quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice